PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Triphala-treated groups showed significantly reduced low-density lipoprotein-cholesterol, total cholesterol, and triglycerides; it also led to a statistically significant decrease in body weight, BMI, and waist circumference in obese patients [PMID:33886393].
Triphala significantly decreased fasting blood glucose levels in diabetic patients [PMID:33886393].
Triphala churna significantly reduced plasma glucose and improved oxidative stress parameters in the lens tissues of diabetic rats [PMID:35168075].
In vitro and in vivo (zebrafish) experiments showed antitumor effects on cell metabolic activity, migration, invasion, apoptosis, and proliferation [PMID:38493718].
Triphala has shown beneficial therapeutic effects on pain, bleeding, and swelling, and helps in preventing recurrence [PMID:40458338].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 38493718 (2024) — The antitumor effects of herbal medicine Triphala on oral cancer by inactivating PI3K/Akt signaling pathway: based on the network pharmacology, molecular docking, in vitro and in vivo experimental validation. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 2.PMID: 24872616 (2014) — Role of Triphala in dentistry. · Journal of Indian Society of Periodontology
- 3.PMID: 40401115 (2025) — Triphala's characteristics and potential therapeutic uses in modern health. · International journal of physiology, pathophysiology and pharmacology
- 4.PMID: 28696777 (2017) — Therapeutic Uses of Triphala in Ayurvedic Medicine. · Journal of alternative and complementary medicine (New York, N.Y.)
- 5.PMID: 35168075